CRISPR guide RNA design for research applications

FEBS Journal

Volumn , Issue , 2016, Pages 3232-3238

  Mohr, Stephanie E ^a   Hu, Yanhui ^a   Ewen Campen, Benjamin ^a   Housden, Benjamin E ^a   Viswanatha, Raghuvir ^a   Perrimon, Norbert ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

bioinformatics; CRISPR Cas9; CRISPRa; CRISPRi; gene editing; genome annotation; genome engineering

Indexed keywords

GUIDE RNA;

BIOINFORMATICS; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT ACTIVATION; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT INTERFERENCE; CRISPR CAS SYSTEM; CRISPR CAS9 SYSTEM; GENE EXPRESSION; GENE SEQUENCE; HEMIZYGOTE; HETEROZYGOTE; HUMAN; IN VIVO STUDY; NONHUMAN; NUCLEOSOME; OPEN READING FRAME; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RNA ANALYSIS; RNA INTERFERENCE;

EID: 84986216625     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.13777     Document Type: Review

References (40)

1. Cathomen T & Joung JK (2008) Zinc-finger nucleases: the next generation emerges. Mol Ther 16, 1200–1207.
2. Joung JK & Sander JD (2013) TALENs: a widely applicable technology for targeted genome editing. Nat Rev Mol Cell Biol 14, 49–55.
3. Wright AV, Nunez JK & Doudna JA (2016) Biology and applications of CRISPR systems: harnessing nature's toolbox for genome engineering. Cell 164, 29–44.
4. Gilbert LA, Larson MH, Morsut L, Liu Z, Brar GA, Torres SE, Stern-Ginossar N, Brandman O, Whitehead EH, Doudna JA et al. (2013) CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 154, 442–451.
5. Sander JD & Joung JK (2014) CRISPR-Cas systems for editing, regulating and targeting genomes. Nat Biotechnol 32, 347–355.
6. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA & Charpentier E (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816–821.
7. Ran FA, Cong L, Yan WX, Scott DA, Gootenberg JS, Kriz AJ, Zetsche B, Shalem O, Wu X, Makarova KS et al. (2015) In vivo genome editing using Staphylococcus aureus Cas9. Nature 520, 186–191.
8. Zetsche B, Gootenberg JS, Abudayyeh OO, Slaymaker IM, Makarova KS, Essletzbichler P, Volz SE, Joung J, van der Oost J, Regev A et al. (2015) Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 163, 759–771.
9. Barrangou R, Birmingham A, Wiemann S, Beijersbergen RL, Hornung V & Smith A (2015) Advances in CRISPR-Cas9 genome engineering: lessons learned from RNA interference. Nucleic Acids Res 43, 3407–3419.
10. Lin Y, Cradick TJ, Brown MT, Deshmukh H, Ranjan P, Sarode N, Wile BM, Vertino PM, Stewart FJ & Bao G (2014) CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences. Nucleic Acids Res 42, 7473–7485.
11. Wang X, Wang Y, Wu X, Wang J, Wang Y, Qiu Z, Chang T, Huang H, Lin RJ & Yee JK (2015) Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors. Nat Biotechnol 33, 175–178.
12. Kim D, Kim S, Kim S, Park J & Kim JS (2016) Genome-wide target specificities of CRISPR-Cas9 nucleases revealed by multiplex Digenome-seq. Genome Res 26, 406–415.
13. Tsai SQ, Zheng Z, Nguyen NT, Liebers M, Topkar VV, Thapar V, Wyvekens N, Khayter C, Iafrate AJ, Le LP et al. (2015) GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat Biotechnol 33, 187–197.
14. Peng R, Lin G & Li J (2015) Potential pitfalls of CRISPR/Cas9-mediated genome editing. FEBS J 283, 1218–1231.
15. Hartenian E & Doench JG (2015) Genetic screens and functional genomics using CRISPR/Cas9 technology. FEBS J 282, 1383–1393.
16. Wu X, Kriz AJ & Sharp PA (2014) Target specificity of the CRISPR-Cas9 system. Quant Biol 2, 59–70.
17. Hendel A, Fine EJ, Bao G & Porteus MH (2015) Quantifying on- and off-target genome editing. Trends Biotechnol 33, 132–140.
18. Farboud B & Meyer BJ (2015) Dramatic enhancement of genome editing by CRISPR/Cas9 through improved guide RNA design. Genetics 199, 959–971.
19. Gilbert LA, Horlbeck MA, Adamson B, Villalta JE, Chen Y, Whitehead EH, Guimaraes C, Panning B, Ploegh HL, Bassik MC et al. (2014) Genome-scale CRISPR-mediated control of gene repression and activation. Cell 159, 647–661.
20. Konermann S, Brigham MD, Trevino AE, Joung J, Abudayyeh OO, Barcena C, Hsu PD, Habib N, Gootenberg JS, Nishimasu H et al. (2015) Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature 517, 583–588.
21. Horlbeck MA, Witkowsky LB, Guglielmi B, Replogle JM, Gilbert LA, Villalta JE, Torigoe SE, Tjian R & Weissman JS (2016) Nucleosomes impede Cas9 access to DNA in vivo and in vitro. Elife 5, e12677.
22. Qi LS, Larson MH, Gilbert LA, Doudna JA, Weissman JS, Arkin AP & Lim WA (2013) Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 152, 1173–1183.
23. Ghosh S, Tibbit C & Liu JL (2016) Effective knockdown of Drosophila long non-coding RNAs by CRISPR interference. Nucleic Acids Res 44, e84.
24. Mandegar MA, Huebsch N, Frolov EB, Shin E, Truong A, Olvera MP, Chan AH, Miyaoka Y, Holmes K, Spencer CI et al. (2016) CRISPR interference efficiently induces specific and reversible gene silencing in human iPSCs. Cell Stem Cell 18, 541–553.
25. Doench JG, Fusi N, Sullender M, Hegde M, Vaimberg EW, Donovan KF, Smith I, Tothova Z, Wilen C, Orchard R et al. (2016) Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat Biotechnol 34, 184–191.
26. Chavez A, Scheiman J, Vora S, Pruitt BW, Tuttle M, P R Iyer E, Lin S, Kiani S, Guzman CD, Wiegand DJ et al. (2015) Highly efficient Cas9-mediated transcriptional programming. Nat Methods 12, 326–328.
27. Jamal M, Khan FA, Da L, Habib Z, Dai J & Cao G (2015) Keeping CRISPR/Cas on-target. Curr Issues Mol Biol 20, 1–20.
28. Heigwer F, Kerr G & Boutros M (2014) E-CRISP: fast CRISPR target site identification. Nat Methods 11, 122–123.
29. Montague TG, Cruz JM, Gagnon JA, Church GM & Valen E (2014) CHOPCHOP: a CRISPR/Cas9 and TALEN web tool for genome editing. Nucleic Acids Res 42, W401–W407.
30. Naito Y, Hino K, Bono H & Ui-Tei K (2015) CRISPRdirect: software for designing CRISPR/Cas guide RNA with reduced off-target sites. Bioinformatics 31, 1120–1123.
31. Liu H, Wei Z, Dominguez A, Li Y, Wang X & Qi LS (2015) CRISPR-ERA: a comprehensive design tool for CRISPR-mediated gene editing, repression and activation. Bioinformatics 31, 3676–3678.
32. Du D & Qi LS (2016) CRISPR technology for genome activation and repression in mammalian cells. Cold Spring Harb Protoc 2016, pdb.prot090175.
33. Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelsen TS, Heckl D, Ebert BL, Root DE, Doench JG et al. (2014) Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343, 84–87.
34. Wang T, Wei JJ, Sabatini DM & Lander ES (2014) Genetic screens in human cells using the CRISPR-Cas9 system. Science 343, 80–84.
35. Shi J, Wang E, Milazzo JP, Wang Z, Kinney JB & Vakoc CR (2015) Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains. Nat Biotechnol 33, 661–667.
36. Pruitt KD, Brown GR, Hiatt SM, Thibaud-Nissen F, Astashyn A, Ermolaeva O, Farrell CM, Hart J, Landrum MJ, McGarvey KM et al. (2014) RefSeq: an update on mammalian reference sequences. Nucleic Acids Res 42, D756–D763.
37. Herrero J, Muffato M, Beal K, Fitzgerald S, Gordon L, Pignatelli M, Vilella AJ, Searle SM, Amode R, Brent S et al. (2016) Ensembl comparative genomics resources. Database (Oxford) 2016, doi: 10.1093/database/bav096.
38. Speir ML, Zweig AS, Rosenbloom KR, Raney BJ, Paten B, Nejad P, Lee BT, Learned K, Karolchik D, Hinrichs AS et al. (2016) The UCSC Genome Browser database: 2016 update. Nucleic Acids Res 44, D717–D725.
39. Hart T, Chandrashekhar M, Aregger M, Steinhart Z, Brown KR, MacLeod G, Mis M, Zimmermann M, Fradet-Turcotte A, Sun S et al. (2015) High-resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities. Cell 163, 1515–1526.
40. Bae S, Kweon J, Kim HS & Kim JS (2014) Microhomology-based choice of Cas9 nuclease target sites. Nat Methods 11, 705–706.